| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42cbc3b8d65987fd732a332a080a6596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3469749340c7eb151141a9b108a44108 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
1996-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f5ebef758ceb3e5dae7d374361464c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a076d04828c3305d8f8cf1e05e08adbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a328c28b1041674b393a47e42f3339e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_799ce27b167977aff385cba876dd52c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a5ce40aa02b5658620e14c4046155a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b714e6927eee343c96fd2f3ea64d02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690868e82aaae911d88136ef2e853b06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d8a940b4ca69c7e89dce2c6669af36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf6c8e10dacfb7b2870cccd02899bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7cf7620eee4103e811837931715d76 |
| publicationDate |
1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2141342-C1 |
| titleOfInvention |
Method of preparing human immunoglobulin for intravenous administration against tick-borne encephalitis |
| abstract |
FIELD: medicine, immunology. SUBSTANCE: invention relates to the production of specific immunoglobulin for an intravenous administration. Method involves the isolation of the specific immunoglobulin fraction using ethanol at low temperatures. Donor plasma is fractionated up to the stage of immunoglobulin dried precipitate preparing which is dissolved in 2% glucose solution and pepsin is added. After proteolysis an enzyme is removed with aluminium hydroxide, pH value of solution is brought about to 6.5-7.5 followed by sterilizing filtration and settling the preparation to form nonstable proteins precipitate. The precipitate is removed by centrifugation at 6000 rev/min and the end product is obtained after sterilizing filtration. Obtained human immunoglobulin against tick-borne encephalitis can be used for an intravenous administration. EFFECT: low an anticomplementary activity of the preparation. 1 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639261-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101352571-B |
| priorityDate |
1996-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |